initiates with a BUY @11.08. Multiple Q4 catalysts, looks cheap here and money should start flowing in from other biotechs like ACRX and HALO over next week or two.
upgrades to NEUTRAL @4.280. $arr could trade up to $4.40 by the time the company reports.
initiates with a BUY @166.9. Sally Smith is an exemplar CEO and the concept is very popular. Further room to grow and exploiting other markets with Pizza Rev. Excellent execution and great fundamentals. Gross margins may fall however as wing prices have been low